{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T18:20:46Z","timestamp":1789928446747,"version":"4.0.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,2,14]],"date-time":"2014-02-14T00:00:00Z","timestamp":1392336000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/2051-5960-2-20","type":"journal-article","created":{"date-parts":[[2014,2,14]],"date-time":"2014-02-14T12:03:58Z","timestamp":1392379438000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Autophagy-lysosome pathway associated neuropathology and axonal degeneration in the brains of alpha-galactosidase A-deficient mice"],"prefix":"10.1186","volume":"2","author":[{"given":"Michael P","family":"Nelson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonia E","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrel B","family":"O\u2019Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie M","family":"Percival","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar A","family":"Jaimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G","family":"Warnock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J","family":"Shacka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,14]]},"reference":[{"issue":"21","key":"96_CR1","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","volume":"276","author":"RO Brady","year":"1967","unstructured":"Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L: Enzymatic defect in Fabry\u2019s disease. Ceramidetrihexosidase deficiency. N Engl J Med 1967, 276(21):1163\u20131167. 10.1056\/NEJM196705252762101","journal-title":"N Engl J Med"},{"issue":"4","key":"96_CR2","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s00428-007-0468-6","volume":"451","author":"H Askari","year":"2007","unstructured":"Askari H, Kaneski CR, Semino-Mora C, Desai P, Ang A, Kleiner DE, Perlee LT, Quezado M, Spollen LE, Wustman BA, Schiffmann R: Cellular and tissue localization of globotriaosylceramide in Fabry disease. Virchows Arch: Int J Pathol 2007, 451(4):823\u2013834. doi:10.1007\/s00428\u2013007\u20130468\u20136 10.1007\/s00428-007-0468-6","journal-title":"Virchows Arch: Int J Pathol"},{"issue":"1","key":"96_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.pharmthera.2009.01.003","volume":"122","author":"R Schiffmann","year":"2009","unstructured":"Schiffmann R: Fabry disease. Pharmacol Therapeut 2009, 122(1):65\u201377. doi:10.1016\/j.pharmthera.2009.01.003 10.1016\/j.pharmthera.2009.01.003","journal-title":"Pharmacol Therapeut"},{"key":"96_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1471-2377-11-61","volume":"11","author":"A Burlina","year":"2011","unstructured":"Burlina A, Sims K, Politei J, Bennett G, Baron R, Sommer C, M\u00f8ller A, Hilz M: Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel. BMC Neurol 2011, 11: 61. doi:10.1186\/1471\u20132377\u201311\u201361 10.1186\/1471-2377-11-61","journal-title":"BMC Neurol"},{"key":"96_CR5","volume-title":"Fabry disease: perspectives from 5 years of FOS","author":"A Mehta","year":"2006","unstructured":"Mehta A, Beck M, Sunder-Plassmann G: Fabry disease: perspectives from 5 years of FOS. Oxford, England: Oxford PharmaGenesis; 2006."},{"issue":"3","key":"96_CR6","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1161\/STROKEAHA.108.526293","volume":"40","author":"K Sims","year":"2009","unstructured":"Sims K, Politei J, Banikazemi M, Lee P: Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry. Stroke; J Cereb Circ 2009, 40(3):788\u2013794. doi:10.1161\/STROKEAHA.108.526293 10.1161\/STROKEAHA.108.526293","journal-title":"Stroke; J Cereb Circ"},{"issue":"1","key":"96_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ana.410400105","volume":"40","author":"P Mitsias","year":"1996","unstructured":"Mitsias P, Levine S: Cerebrovascular complications of Fabry\u2019s disease. Ann Neurol 1996, 40(1):8\u201317. doi:10.1002\/ana.410400105 10.1002\/ana.410400105","journal-title":"Ann Neurol"},{"issue":"2","key":"96_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1600-0404.2012.01661.x","volume":"126","author":"A Bersano","year":"2012","unstructured":"Bersano A, Lanfranconi S, Valcarenghi C, Bresolin N, Micieli G, Baron P: Neurological features of Fabry disease: clinical, pathophysiological aspects and therapy. Acta Neurol Scand 2012, 126(2):77\u201397. doi:10.1111\/j.1600\u20130404.2012.01661.x 10.1111\/j.1600-0404.2012.01661.x","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"96_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.brainresbull.2003.09.021","volume":"62","author":"D Moore","year":"2003","unstructured":"Moore D, Altarescu G, Barker W, Patronas N, Herscovitch P, Schiffmann R: White matter lesions in Fabry disease occur in 'prior\u2019 selectively hypometabolic and hyperperfused brain regions. Brain Res Bull 2003, 62(3):231\u2013240. 10.1016\/j.brainresbull.2003.09.021","journal-title":"Brain Res Bull"},{"issue":"2","key":"96_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/BF00690579","volume":"56","author":"F Tagliavini","year":"1982","unstructured":"Tagliavini F, Pietrini V, Gemignani F, Lechi A, Pallini R, Federico A: Anderson-Fabry\u2019s disease: neuropathological and neurochemical investigation. Acta Neuropathol 1982, 56(2):93\u201398. doi:10.1007\/BF00690579 10.1007\/BF00690579","journal-title":"Acta Neuropathol"},{"issue":"9","key":"96_CR11","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.4161\/auto.25560","volume":"9","author":"B Loos","year":"2013","unstructured":"Loos B, Engelbrecht A-M, Lockshin R, Klionsky D, Zakeri Z: The variability of autophagy and cell death susceptibility: Unanswered questions. Autophagy 2013, 9(9):1270\u20131285. 10.4161\/auto.25560","journal-title":"Autophagy"},{"issue":"6","key":"96_CR12","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nrm1660","volume":"6","author":"J Lum","year":"2005","unstructured":"Lum J, DeBerardinis R, Thompson C: Autophagy in metazoans: cell survival in the land of plenty. Nature Rev Mol Cell Biol 2005, 6(6):439\u2013448. doi:10.1038\/nrm1660 10.1038\/nrm1660","journal-title":"Nature Rev Mol Cell Biol"},{"key":"96_CR13","first-page":"331","volume-title":"Autophagy of the nervous system","author":"JJ Shacka","year":"2011","unstructured":"Shacka JJ: Lysosome storage disorders on the brain: the autophagy-lysosome pathway contributes to disease pathophysiology and may be utilized for therapeutic benefit. In Autophagy of the nervous system. Edited by: Yue Z, Chu CT. Singapore: World Scientific; 2011:331\u2013354."},{"issue":"5","key":"96_CR14","doi-asserted-by":"publisher","first-page":"589","DOI":"10.4161\/auto.6.5.11943","volume":"6","author":"M Ch\u00e9vrier","year":"2010","unstructured":"Ch\u00e9vrier M, Brakch N, C\u00e9line L, Gent D, Ramdani Y, Moll S, Djavaheri-Mergny M, Brasse-Lagnel C, Laquerriere A, Barbey F, Bekri S: Autophagosome maturation is impaired in Fabry Disease. Autophagy 2010, 6(5):589\u2013599. doi:10.4161\/auto.6.5.11943 10.4161\/auto.6.5.11943","journal-title":"Autophagy"},{"issue":"3","key":"96_CR15","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/BF00296520","volume":"90","author":"M Uchino","year":"1995","unstructured":"Uchino M, Uyama E, Kawano H, Hokamaki J, Kugiyama K, Murakami Y, Yasue H, Ando M: A histochemical and electron microscopic study of skeletal and cardiac muscle from a Fabry disease patient and carrier. Acta Neuropathol 1995, 90(3):334\u2013338. doi:10.1007\/BF00296520 10.1007\/BF00296520","journal-title":"Acta Neuropathol"},{"issue":"2","key":"96_CR16","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/01.ASN.0000043901.45141.D4","volume":"14","author":"D Eitzman","year":"2003","unstructured":"Eitzman D, Bodary P, Shen Y, Khairallah C, Wild S, Abe A, Shaffer-Hartman J, Shayman J: Fabry disease in mice is associated with age-dependent susceptibility to vascular thrombosis. J Am Soc Nephrol: JASN 2003, 14(2):298\u2013302. 10.1097\/01.ASN.0000043901.45141.D4","journal-title":"J Am Soc Nephrol: JASN"},{"key":"96_CR17","volume-title":"PloS One","author":"A Nguyen Dinh Cat","year":"2012","unstructured":"Nguyen Dinh Cat A, Escoubet B, Agrapart V, Griol-Charhbili V, Schoeb T, Feng W, Jaimes E, Warnock D, Jaisser F: Cardiomyopathy and response to enzyme replacement therapy in a male mouse model for Fabry disease. PloS One 2012, 7(5):\u2009. doi:10.1371\/journal.pone.0033743"},{"key":"96_CR18","volume-title":"Proceedings of the National Academy of Sciences 94","author":"T Ohshima","year":"1997","unstructured":"Ohshima T: alpha -Galactosidase A deficient mice: a model of fabry disease. Proceedings of the National Academy of Sciences 94 1997. doi:10.1073\/pnas.94.6.2540"},{"issue":"1","key":"96_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.nbd.2008.09.001","volume":"33","author":"L Rodrigues","year":"2009","unstructured":"Rodrigues L, Ferraz M, Rodrigues D, Pais-Vieira M, Lima D, Brady R, Sousa M, S\u00e1-Miranda M: Neurophysiological, behavioral and morphological abnormalities in the Fabry knockout mice. Neurobiol Dis 2009, 33(1):48\u201356. doi:10.1016\/j.nbd.2008.09.001 10.1016\/j.nbd.2008.09.001","journal-title":"Neurobiol Dis"},{"issue":"4","key":"96_CR20","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00428-011-1051-8","volume":"458","author":"C Valbuena","year":"2011","unstructured":"Valbuena C, Oliveira J, Carneiro F, Relvas S, Ganh\u00e3o M, S\u00e1-Miranda M, Rodrigues L: Kidney histologic alterations in \u03b1-Galactosidase-deficient mice. Virchows Arch: Int J Pathol 2011, 458(4):477\u2013486. doi:10.1007\/s00428\u2013011\u20131051\u20138 10.1007\/s00428-011-1051-8","journal-title":"Virchows Arch: Int J Pathol"},{"issue":"10","key":"96_CR21","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1089\/10430349950017671","volume":"10","author":"R Ziegler","year":"1999","unstructured":"Ziegler R, Yew N, Li C, Cherry M, Berthelette P, Romanczuk H, Ioannou Y, Zeidner K, Desnick R, Cheng S: Correction of enzymatic and lysosomal storage defects in Fabry mice by adenovirus-mediated gene transfer. Hum Gene Ther 1999, 10(10):1667\u20131682. doi:10.1089\/10430349950017671?2 10.1089\/10430349950017671","journal-title":"Hum Gene Ther"},{"key":"96_CR22","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/978-1-62703-398-5_16","volume":"1008","author":"SN Pompey","year":"2013","unstructured":"Pompey SN, Michaely P, Luby-Phelps K: Quantitative fluorescence co-localization to study protein-receptor complexes. Methods Mol Biol (Clifton, NJ) 2013, 1008: 439\u2013453. doi:10.1007\/978\u20131-62703\u2013398\u20135_16 10.1007\/978-1-62703-398-5_16","journal-title":"Methods Mol Biol (Clifton, NJ)"},{"issue":"4","key":"96_CR23","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4161\/auto.19496","volume":"8","author":"D Klionsky","year":"2012","unstructured":"Klionsky D, Abdalla F, Abeliovich H, Abraham R, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso J, Ahn H, Ait-Mohamed O, Ait-Si-Ali S, Akematsu T, Akira S, Al-Younes H, Al-Zeer M, Albert M, Albin R, Alegre-Abarrategui J, Aleo M, Alirezaei M, Almasan A, Almonte-Becerril M, Amano A, Amaravadi R, Amarnath S, Amer A, Andrieu-Abadie N, et al.: Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012, 8(4):445\u2013544. 10.4161\/auto.19496","journal-title":"Autophagy"},{"issue":"12","key":"96_CR24","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1021\/cn300145z","volume":"3","author":"B Mader","year":"2012","unstructured":"Mader B, Pivtoraiko V, Flippo H, Klocke B, Roth K, Mangieri L, Shacka J: Rotenone inhibits autophagic flux prior to inducing cell death. ACS Chem Neurosci 2012, 3(12):1063\u20131072. doi:10.1021\/cn300145z 10.1021\/cn300145z","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"96_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.brainresbull.2012.03.003","volume":"88","author":"J Shacka","year":"2012","unstructured":"Shacka J: Mouse models of neuronal ceroid lipofuscinoses: useful pre-clinical tools to delineate disease pathophysiology and validate therapeutics. Brain Res Bull 2012, 88(1):43\u201357. doi:10.1016\/j.brainresbull.2012.03.003 10.1016\/j.brainresbull.2012.03.003","journal-title":"Brain Res Bull"},{"issue":"2","key":"96_CR26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jchemneu.2008.10.003","volume":"37","author":"W H\u00e4rtig","year":"2009","unstructured":"H\u00e4rtig W, Reichenbach A, Voigt C, Boltze J, Bulavina L, Schuhmann M, Seeger J, Schusser G, Freytag C, Grosche J: Triple fluorescence labelling of neuronal, glial and vascular markers revealing pathological alterations in various animal models. J Chem Neuroanat 2009, 37(2):128\u2013138. doi:10.1016\/j.jchemneu.2008.10.003 10.1016\/j.jchemneu.2008.10.003","journal-title":"J Chem Neuroanat"},{"issue":"6","key":"96_CR27","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/ana.22400","volume":"69","author":"V Cullen","year":"2011","unstructured":"Cullen V, Sardi S, Ng J, Xu Y-H, Sun Y, Tomlinson J, Kolodziej P, Kahn I, Saftig P, Woulfe J, Rochet J-C, Glicksman M, Cheng S, Grabowski G, Shihabuddin L, Schlossmacher M: Acid \u03b2-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter \u03b1-synuclein processing. Ann Neurol 2011, 69(6):940\u2013953. doi:10.1002\/ana.22400 10.1002\/ana.22400","journal-title":"Ann Neurol"},{"issue":"1","key":"96_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","volume":"146","author":"J Mazzulli","year":"2011","unstructured":"Mazzulli J, Xu Y-H, Sun Y, Knight A, McLean P, Caldwell G, Sidransky E, Grabowski G, Krainc D: Gaucher disease glucocerebrosidase and \u03b1-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 2011, 146(1):37\u201352. doi:10.1016\/j.cell.2011.06.001 10.1016\/j.cell.2011.06.001","journal-title":"Cell"},{"issue":"4","key":"96_CR29","first-page":"1193","volume":"114","author":"V Pivtoraiko","year":"2010","unstructured":"Pivtoraiko V, Harrington A, Mader B, Luker A, Caldwell G, Caldwell K, Roth K, Shacka J: Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction. J Neurochem 2010, 114(4):1193\u20131204. doi:10.1111\/j.1471\u20134159.2010.06838.x","journal-title":"J Neurochem"},{"key":"96_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1756-6606-1-17","volume":"1","author":"L Qiao","year":"2008","unstructured":"Qiao L, Hamamichi S, Caldwell K, Caldwell G, Yacoubian T, Wilson S, Xie Z-L, Speake L, Parks R, Crabtree D, Liang Q, Crimmins S, Schneider L, Uchiyama Y, Iwatsubo T, Zhou Y, Peng L, Lu Y, Standaert D, Walls K, Shacka J, Roth K, Zhang J: Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity. Mol Brain 2008, 1: 17. doi:10.1186\/1756\u20136606\u20131-17 10.1186\/1756-6606-1-17","journal-title":"Mol Brain"},{"issue":"36","key":"96_CR31","doi-asserted-by":"publisher","first-page":"9678","DOI":"10.1021\/bi800699v","volume":"47","author":"D Sevlever","year":"2008","unstructured":"Sevlever D, Jiang P, Yen S-HC: Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species. Biochemistry 2008, 47(36):9678\u20139687. doi:10.1021\/bi800699v 10.1021\/bi800699v","journal-title":"Biochemistry"},{"issue":"5","key":"96_CR32","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/nn1443","volume":"8","author":"L Chen","year":"2005","unstructured":"Chen L, Feany M: Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Nat Neurosci 2005, 8(5):657\u2013663. doi:10.1038\/nn1443 10.1038\/nn1443","journal-title":"Nat Neurosci"},{"issue":"2","key":"96_CR33","first-page":"160","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg M, Shen J, Takio K, Iwatsubo T: alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 2002, 4(2):160\u2013164. doi:10.1038\/ncb748","journal-title":"Nat Cell Biol"},{"issue":"50","key":"96_CR34","doi-asserted-by":"publisher","first-page":"49071","DOI":"10.1074\/jbc.M208046200","volume":"277","author":"M Hasegawa","year":"2002","unstructured":"Hasegawa M, Fujiwara H, Nonaka T, Wakabayashi K, Takahashi H, Lee V, Trojanowski J, Mann D, Iwatsubo T: Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions. J Biol Chem 2002, 277(50):49071\u201349076. doi:10.1074\/jbc.M208046200 10.1074\/jbc.M208046200","journal-title":"J Biol Chem"},{"issue":"45","key":"96_CR35","doi-asserted-by":"publisher","first-page":"44405","DOI":"10.1074\/jbc.M308041200","volume":"278","author":"G Tofaris","year":"2003","unstructured":"Tofaris G, Razzaq A, Ghetti B, Lilley K, Spillantini M: Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function. J Biol Chem 2003, 278(45):44405\u201344411. doi:10.1074\/jbc.M308041200 10.1074\/jbc.M308041200","journal-title":"J Biol Chem"},{"issue":"7","key":"96_CR36","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.tins.2013.04.001","volume":"36","author":"Y Yang","year":"2013","unstructured":"Yang Y, Coleman M, Zhang L, Zheng X, Yue Z: Autophagy in axonal and dendritic degeneration. Trends Neurosci 2013, 36(7):418\u2013428. doi:10.1016\/j.tins.2013.04.001 10.1016\/j.tins.2013.04.001","journal-title":"Trends Neurosci"},{"issue":"3","key":"96_CR37","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1089\/ars.2008.2263","volume":"11","author":"V Pivtoraiko","year":"2009","unstructured":"Pivtoraiko V, Stone S, Roth K, Shacka J: Oxidative stress and autophagy in the regulation of lysosome-dependent neuron death. Antioxid Redox Signal 2009, 11(3):481\u2013496. doi:10.1089\/ars.2008.2263 10.1089\/ars.2008.2263","journal-title":"Antioxid Redox Signal"},{"issue":"8","key":"96_CR38","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1523\/JNEUROSCI.5577-06.2007","volume":"27","author":"J Shacka","year":"2007","unstructured":"Shacka J, Klocke B, Young C, Shibata M, Olney J, Uchiyama Y, Saftig P, Roth K: Cathepsin D deficiency induces persistent neurodegeneration in the absence of Bax-dependent apoptosis. J Neurosci: J Soc Neurosci 2007, 27(8):2081\u20132090. doi:10.1523\/JNEUROSCI.5577\u201306.2007 10.1523\/JNEUROSCI.5577-06.2007","journal-title":"J Neurosci: J Soc Neurosci"},{"issue":"1\u20132","key":"96_CR39","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1089\/ars.2006.8.197","volume":"8","author":"A Terman","year":"2006","unstructured":"Terman A, Brunk U: Oxidative stress, accumulation of biological 'garbage\u2019, and aging. Antioxid Redox Signal 2006, 8(1\u20132):197\u2013204. doi:10.1089\/ars.2006.8.197","journal-title":"Antioxid Redox Signal"},{"issue":"21","key":"96_CR40","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.1093\/emboj\/19.21.5720","volume":"19","author":"Y Kabeya","year":"2000","unstructured":"Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y, Yoshimori T: LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 2000, 19(21):5720\u20135728. doi:10.1093\/emboj\/19.21.5720 10.1093\/emboj\/19.21.5720","journal-title":"EMBO J"},{"key":"96_CR41","volume-title":"PloS one","author":"M Liebau","year":"2013","unstructured":"Liebau M, Braun F, H\u00f6pker K, Weitbrecht C, Bartels V, M\u00fcller R-U, Brodesser S, Saleem M, Benzing T, Schermer B, Cybulla M, Kurschat C: Dysregulated autophagy contributes to podocyte damage in Fabry\u2019s disease. PloS one 2013, 8(5):\u2009. doi:10.1371\/journal.pone.0063506"},{"issue":"6","key":"96_CR42","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1073\/pnas.1112848109","volume":"109","author":"N Jaber","year":"2012","unstructured":"Jaber N, Dou Z, Chen J-SS, Catanzaro J, Jiang Y-PP, Ballou LM, Selinger E, Ouyang X, Lin RZ, Zhang J, Zong W-XX: Class III PI3K Vps34 plays an essential role in autophagy and in heart and liver function. Proc Natl Acad Sci USA 2012, 109(6):2003\u20132008. doi:10.1073\/pnas.1112848109 10.1073\/pnas.1112848109","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"96_CR43","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.bbrc.2009.03.039","volume":"382","author":"M Shibata","year":"2009","unstructured":"Shibata M, Yoshimura K, Furuya N, Koike M, Ueno T, Komatsu M, Arai H, Tanaka K, Kominami E, Uchiyama Y: The MAP1-LC3 conjugation system is involved in lipid droplet formation. Biochem Biophys Res Commun 2009, 382(2):419\u2013423. doi:10.1016\/j.bbrc.2009.03.039 10.1016\/j.bbrc.2009.03.039","journal-title":"Biochem Biophys Res Commun"},{"issue":"15","key":"96_CR44","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.1523\/JNEUROSCI.4860-11.2012","volume":"32","author":"S Keilani","year":"2012","unstructured":"Keilani S, Lun Y, Stevens A, Williams H, Sjoberg E, Khanna R, Valenzano K, Checler F, Buxbaum J, Yanagisawa K, Lockhart D, Wustman B, Gandy S: Lysosomal dysfunction in a mouse model of Sandhoff disease leads to accumulation of ganglioside-bound amyloid-\u03b2 peptide. J Neurosci: J Soc Neurosci 2012, 32(15):5223\u20135236. doi:10.1523\/JNEUROSCI.4860\u201311.2012 10.1523\/JNEUROSCI.4860-11.2012","journal-title":"J Neurosci: J Soc Neurosci"},{"issue":"8","key":"96_CR45","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1523\/JNEUROSCI.3809-03.2004","volume":"24","author":"H-J Lee","year":"2004","unstructured":"Lee H-J, Khoshaghideh F, Patel S, Lee S-J: Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway. J Neurosci: J Soc Neurosci 2004, 24(8):1888\u20131896. doi:10.1523\/JNEUROSCI.3809\u201303.2004 10.1523\/JNEUROSCI.3809-03.2004","journal-title":"J Neurosci: J Soc Neurosci"},{"issue":"35","key":"96_CR46","doi-asserted-by":"publisher","first-page":"23542","DOI":"10.1074\/jbc.M801992200","volume":"283","author":"T Vogiatzi","year":"2008","unstructured":"Vogiatzi T, Xilouri M, Vekrellis K, Stefanis L: Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J Biol Chem 2008, 283(35):23542\u201323556. doi:10.1074\/jbc.M801992200 10.1074\/jbc.M801992200","journal-title":"J Biol Chem"},{"issue":"5910","key":"96_CR47","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.1166088","volume":"323","author":"Q Yang","year":"2009","unstructured":"Yang Q, She H, Gearing M, Colla E, Lee M, Shacka J, Mao Z: Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy. Science (New York, NY) 2009, 323(5910):124\u2013127. doi:10.1126\/science.1166088 10.1126\/science.1166088","journal-title":"Science (New York, NY)"},{"issue":"12","key":"96_CR48","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1016\/j.bbamem.2006.05.027","volume":"1758","author":"T Kolter","year":"2006","unstructured":"Kolter T, Sandhoff K: Sphingolipid metabolism diseases. Biochim Biophys Acta 2006, 1758(12):2057\u20132079. doi:10.1016\/j.bbamem.2006.05.027 10.1016\/j.bbamem.2006.05.027","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"96_CR49","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/ana.23614","volume":"72","author":"M Gegg","year":"2012","unstructured":"Gegg M, Burke D, Heales S, Cooper J, Hardy J, Wood N, Schapira A: Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains. Ann Neurol 2012, 72(3):455\u2013463. doi:10.1002\/ana.23614 10.1002\/ana.23614","journal-title":"Ann Neurol"},{"issue":"1","key":"96_CR50","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ymgme.2003.11.004","volume":"81","author":"A Lwin","year":"2004","unstructured":"Lwin A, Orvisky E, Goker-Alpan O, LaMarca M, Sidransky E: Glucocerebrosidase mutations in subjects with parkinsonism. Mol Genet Metab 2004, 81(1):70\u201373. 10.1016\/j.ymgme.2003.11.004","journal-title":"Mol Genet Metab"},{"issue":"1","key":"96_CR51","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/mds.20675","volume":"21","author":"S Buechner","year":"2006","unstructured":"Buechner S, De Cristofaro M, Ramat S, Borsini W: Parkinsonism and Anderson Fabry\u2019s disease: a case report. Movement Disord: J Movement Disord Soc 2006, 21(1):103\u2013107. doi:10.1002\/mds.20675 10.1002\/mds.20675","journal-title":"Movement Disord: J Movement Disord Soc"},{"issue":"10","key":"96_CR52","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1007\/s11064-011-0516-0","volume":"36","author":"G Wu","year":"2011","unstructured":"Wu G, Huang J, Feng X, Zhang A, Li J, Pang S, Gu K, Dong H, Zhang J, Gao H, Yan B: Decreased expression of lysosomal alpha-galactosiase A gene in sporadic Parkinson\u2019s disease. Neurochem Res 2011, 36(10):1939\u20131944. doi:10.1007\/s11064\u2013011\u20130516\u20130 10.1007\/s11064-011-0516-0","journal-title":"Neurochem Res"},{"issue":"1","key":"96_CR53","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.neulet.2011.05.238","volume":"500","author":"G Wu","year":"2011","unstructured":"Wu G, Pang S, Feng X, Zhang A, Li J, Gu K, Huang J, Dong H, Yan B: Genetic analysis of lysosomal alpha-galactosidase A gene in sporadic Parkinson\u2019s disease. Neuroscience Lett 2011, 500(1):31\u201335. doi:10.1016\/j.neulet.2011.05.238 10.1016\/j.neulet.2011.05.238","journal-title":"Neuroscience Lett"},{"issue":"1\u20132","key":"96_CR54","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jns.2008.04.011","volume":"271","author":"G Wu","year":"2008","unstructured":"Wu G, Yan B, Wang X, Feng X, Zhang A, Xu X, Dong H: Decreased activities of lysosomal acid alpha-D-galactosidase A in the leukocytes of sporadic Parkinson\u2019s disease. J Neurol Sci 2008, 271(1\u20132):168\u2013173. doi:10.1016\/j.jns.2008.04.011","journal-title":"J Neurol Sci"},{"issue":"1","key":"96_CR55","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00418-008-0417-8","volume":"130","author":"G Kolling","year":"2008","unstructured":"Kolling G, Obata F, Gross L, Obrig T: Immunohistologic techniques for detecting the glycolipid Gb(3) in the mouse kidney and nervous system. Histochem Cell Biol 2008, 130(1):157\u2013164. doi:10.1007\/s00418\u2013008\u20130417\u20138 10.1007\/s00418-008-0417-8","journal-title":"Histochem Cell Biol"},{"issue":"3","key":"96_CR56","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.nbd.2003.08.016","volume":"14","author":"U Schueler","year":"2003","unstructured":"Schueler U, Kolter T, Kaneski C, Blusztajn J, Herkenham M, Sandhoff K, Brady R: Toxicity of glucosylsphingosine (glucopsychosine) to cultured neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3. Neurobiol Dis 2003, 14(3):595\u2013601. 10.1016\/j.nbd.2003.08.016","journal-title":"Neurobiol Dis"},{"issue":"6","key":"96_CR57","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/hmg\/ddp580","volume":"19","author":"Y Sun","year":"2010","unstructured":"Sun Y, Liou B, Ran H, Skelton M, Williams M, Vorhees C, Kitatani K, Hannun Y, Witte D, Xu Y-H, Grabowski G: Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits. Hum Mol Genet 2010, 19(6):1088\u20131097. doi:10.1093\/hmg\/ddp580 10.1093\/hmg\/ddp580","journal-title":"Hum Mol Genet"},{"issue":"4","key":"96_CR58","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/hmg\/ddp531","volume":"19","author":"Y Sun","year":"2010","unstructured":"Sun Y, Ran H, Zamzow M, Kitatani K, Skelton M, Williams M, Vorhees C, Witte D, Hannun Y, Grabowski G: Specific saposin C deficiency: CNS impairment and acid beta-glucosidase effects in the mouse. Hum Mol Genet 2010, 19(4):634\u2013647. doi:10.1093\/hmg\/ddp531 10.1093\/hmg\/ddp531","journal-title":"Hum Mol Genet"},{"issue":"1","key":"96_CR59","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1750-3639.2012.00608.x","volume":"23","author":"L Schirmer","year":"2013","unstructured":"Schirmer L, Merkler D, K\u00f6nig F, Br\u00fcck W, Stadelmann C: Neuroaxonal regeneration is more pronounced in early multiple sclerosis than in traumatic brain injury lesions. Brain Pathol (Zurich, Switzerland) 2013, 23(1):2\u201312. doi:10.1111\/j.1750\u20133639.2012.00608.x 10.1111\/j.1750-3639.2012.00608.x","journal-title":"Brain Pathol (Zurich, Switzerland)"},{"issue":"1\u20132","key":"96_CR60","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jns.2011.03.020","volume":"305","author":"R Reisin","year":"2011","unstructured":"Reisin R, Romero C, Marchesoni C, N\u00e1poli G, Kisinovsky I, C\u00e1ceres G, Sevlever G: Brain MRI findings in patients with Fabry disease. J Neurol Sci 2011, 305(1\u20132):41\u201344. doi:10.1016\/j.jns.2011.03.020","journal-title":"J Neurol Sci"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2051-5960-2-20.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2051-5960-2-20\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2051-5960-2-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/2051-5960-2-20.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:07:00Z","timestamp":1630552020000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/2051-5960-2-20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,14]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["96"],"URL":"https:\/\/doi.org\/10.1186\/2051-5960-2-20","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,14]]},"assertion":[{"value":"22 October 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"20"}}